(Australia-NewsWire.Com, September 26, 2017 ) According to the report Asia Pacific Nucleic Acid Labelling Market By Product (Reagents & Kits, Services), By Labelling Technique (PCR, Nick Translation, Random Primer, In-Vitro Transcription, Reverse Transcription), By Application (DNA Sequencing, PCR, FISH, Microarrays, Blotting, In-Situ Hybridization), By End Users (Diagnostic Centres, Research Centres, Hospitals) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (20162021) published by Market Data Forecast, The Asia Pacific Nucleic Acid Labelling Market was worth USD 221.1 million in 2016 and estimated to be growing at a CAGR of 9.9%, to reach USD 354.45 million by 2021. Nucleic Acid Labelling have many applications in fields of drug discovery and identification of new diseases.
DNA and RNA are the information carrying Nucleic acids which are of great significance for protein synthesis. They can be labelled with tags which assists in detection and purification processes. One of the labelling techniques is Nick Translation in which some of the nucleotides of a DNA sequence with their labelled analogues, creating a tagged DNA sequence which can be used as a probe in fluorescent in situ hybridization or blotting techniques. It can also be used for radiolabeling. DNA labelling has various applications in diagnosis and biotechnology.
The primary driving forces of the Asia Pacific Nucleic Acid Labelling Market are increasing funding for R&D in genomics and disease diagnosis, increasing expenditure for health care, increasing demand for personalized healthcare. But, factors like expensive processing techniques and lack of skilled professionals are likely to hinder the growth of market. The Asia Pacific Nucleic Acid Labelling Market is segmented based on Product, Labelling Technique, Application and End-User. Based on Product Reagents and Kits and Services. Based on Labelling Technique PCR, Nick Translation, Random Primer, In-Vitro Transcription and Reverse Transcription. Based on Application DNA Sequencing, PCR, Fluorescence in Situ Hybridization (FISH), Microarrays, Blotting, In-Situ Hybridization. Based on End-Users Diagnostic Centres, Research Centres and Hospitals. Based on Geographical analysis the market is separated into regions of China, India, Japan, South-Korea and Australia. China is leading the market while India is at second place.
Increasing personalized medicines, identifying the genetic modifications and therapeutic areas have enabled China to dominate the market. India is expected to grow the fastest due to government initiatives to develop healthcare infrastructure and making the products cost efficient and increased R&D expenditure. DNA sequencing occupies major share in terms of Applications due to its uses in identification of genetic disorders, tumour genetic variations. Reagents and Kits occupy major share among products segment due to their numerous uses in Diagnostic and Research Centres. Based on End User Research Centres occupy the major share owing to increasing government funding to increase research activity and drug discovery.
Some of the key players dominating this Asia Pacific Nucleic Acid Labelling Market: Thermo Fisher Scientific New England Biolabs PerkinElmer F. Hoffmann La-Roche AG General Electric Company Merck KGaA Enzo Biochem Promega Corporation Vector Laboratories Agilent Technologies
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Media Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/